Search Results

Site Search

Other testing - Insights

Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.

Organic acid disorders - Insights

Check out how Mayo Clinic Laboratories testing for organic acid metabolism disorders can help provide early diagnosis that enable prompt intervention.

Amino acid disorders - Insights

Learn more about how amino acid metabolism testing at Mayo Clinic Laboratories can assist in diagnosing the most preventable and treatable amino acid disorders.

Cardiovascular Pathology Services at Mayo Clinic Laboratories

Cardiovascular pathology focuses on a multidisciplinary approach to the consultative practice. Learn more about our service.

Coccidioides - Insights

Mayo Clinic Laboratories upfront, screening enzyme-linked immunosorbent assay detects Coccidioides antibodies prior to testing by complement fixation (CF) or immunodiffusion (ID). Samples that result as reactive by are subsequently reflexed...

Tick-borne coinfection - Insights

Browse our suite of serological and molecular testing designed to detect tick-borne pathogen coinfections.

Rare diseases - Insights

Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...

Collaborations - Insights

Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.

Monogenic IBD Testing - Mayo Clinic Laboratories

Monogenic inflammatory bowel disease (IBD) refers to a diverse spectrum of rare genetic disorders that present with intestinal inflammation. The majority of patients with monogenic IBD, unlike those with polygenic IBD, show symptoms before...

Confirmatory testing - Insights

Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.